Antibody neutralization and escape by HIV-1
暂无分享,去创建一个
Martin A. Nowak | Natalia L. Komarova | Peter D. Kwong | Xiping Wei | Michael S. Saag | George M. Shaw | M. Nowak | J. Kappes | N. Komarova | G. Shaw | B. Hahn | M. Saag | Xiping Wei | P. Kwong | J. Salazar-Gonzalez | M. Salazar | J. Decker | Shuyi Wang | J. Kilby | Xiaoyun Wu | Julie M. Decker | Shuyi Wang | Beatrice H. Hahn | Jesus F. Salazar-Gonzalez | J. Michael Kilby | H. Hui | John C. Kappes | Maria G. Salazar | Huxiong Hui | Xiaoyun Wu
[1] Alan S. Perelson,et al. A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo , 2003, Journal of Virology.
[2] Sebastian Bonhoeffer,et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.
[3] J. Kappes,et al. Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy , 2002, Antimicrobial Agents and Chemotherapy.
[4] J. Albert,et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. , 1990, AIDS.
[5] M. Oliveberg,et al. High-energy channeling in protein folding. , 1997, Biochemistry.
[6] V. Muñoz,et al. Experimental Identification of Downhill Protein Folding , 2002, Science.
[7] G. Westbrook,et al. A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux , 2001, Nature Neuroscience.
[8] Peter D. Kwong,et al. The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 , 2002, Journal of Virology.
[9] Valerie Daggett,et al. The complete folding pathway of a protein from nanoseconds to microseconds , 2003, Nature.
[10] E. Rosenberg,et al. Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection , 2001, Journal of Virology.
[11] Michael Harpham. December , 1855, The Hospital.
[12] C. Saudan,et al. Denaturant-induced movement of the transition state of protein folding revealed by high-pressure stopped-flow measurements. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Means,et al. A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.
[14] W. Eaton,et al. Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy , 2002, Nature.
[15] V. Pande,et al. Absolute comparison of simulated and experimental protein-folding dynamics , 2002, Nature.
[16] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[17] Lisa J. Lapidus,et al. Measuring the rate of intramolecular contact formation in polypeptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Gruebele,et al. Observation of strange kinetics in protein folding. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Sodroski,et al. Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus , 2000, Journal of Virology.
[20] J. Klafter,et al. Hierarchies and logarithmic oscillations in the temporal relaxation patterns of proteins and other complex systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] Peter D. Kwong,et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.
[22] C. Parsons,et al. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. , 1998, Pharmacological reviews.
[23] M. Corsi,et al. Receptor binding characteristics of the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat cerebral cortical membranes. , 2000, European journal of pharmacology.
[24] D R Burton,et al. gp120: Biologic aspects of structural features. , 2001, Annual review of immunology.
[25] T. Kiefhaber,et al. The speed limit for protein folding measured by triplet-triplet energy transfer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] John W. Mellors,et al. Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences , 1997 .
[27] P. Camilli,et al. Accessory factors in clathrin-dependent synaptic vesicle endocytosis , 2000, Nature Reviews Neuroscience.
[28] H. Katinger,et al. The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 , 2002, Journal of Virology.
[29] Q. Sattentau,et al. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. , 1999, AIDS.
[30] J. Goudsmit,et al. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. , 1994, Virology.
[31] H. Fleury,et al. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals , 1997, Journal of virology.
[32] J. Hofrichter,et al. Rate of Intrachain Diffusion of Unfolded Cytochrome c , 1997 .
[33] Shoji Takada,et al. Microscopic Theory of Protein Folding Rates.II: Local Reaction Coordinates and Chain Dynamics , 2000, cond-mat/0008455.
[34] Joseph Sodroski,et al. Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants , 2001, Journal of Virology.
[35] D. Colquhoun,et al. Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors , 1998, British journal of pharmacology.
[36] T. Oas,et al. Contribution of a buried hydrogen bond to lambda repressor folding kinetics. , 1999, Biochemistry.
[37] D. Montefiori,et al. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. , 1997, The Journal of infectious diseases.
[38] Mark von Zastrow,et al. Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures , 1999, Nature Neuroscience.
[39] Peter D. Kwong,et al. The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.
[40] J. Sodroski,et al. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.
[41] Harry B Gray,et al. The protein-folding speed limit: Intrachain diffusion times set by electron-transfer rates in denatured Ru(NH3)5(His-33)-Zn-cytochrome c , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Myers,et al. HIV glycosylation: what does it portend? , 1992, AIDS research and human retroviruses.
[43] M. Oliveberg,et al. Transient aggregates in protein folding are easily mistaken for folding intermediates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] B. Deurs,et al. Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification , 1993, The Journal of cell biology.
[45] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[46] G. Hummer,et al. Peptide loop-closure kinetics from microsecond molecular dynamics simulations in explicit solvent. , 2002, Journal of the American Chemical Society.
[47] Abraham Pinter,et al. Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades , 2002, Journal of Virology.
[48] Terrence G. Oas,et al. The energy landscape of a fast-folding protein mapped by Ala→Gly Substitutions , 1997, Nature Structural Biology.
[49] M. Ehlers,et al. Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting , 2000, Neuron.
[50] K. Titani,et al. Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. , 1990, The Journal of biological chemistry.
[51] J. Overbaugh,et al. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies , 1997, Journal of virology.
[52] J. Hofrichter,et al. Diffusion-limited contact formation in unfolded cytochrome c: estimating the maximum rate of protein folding. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[53] W A Hendrickson,et al. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. , 2000, Structure.
[54] H. Katinger,et al. Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. , 1999, Immunity.
[55] Shoji Takada,et al. Microscopic theory of protein folding rates. I. Fine structure of the free energy profile and folding routes from a variational approach , 2000, cond-mat/0008454.
[56] D. Thirumalai,et al. Time Scales for the Formation of the Most Probable Tertiary Contacts in Proteins with Applications to Cytochrome c , 1999 .
[57] S. Ghaemmaghami,et al. Folding kinetics of a fluorescent variant of monomeric lambda repressor. , 1998, Biochemistry.
[58] C. Stevens,et al. NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus , 1989, Nature.